Sbir phase 1 (NIH/nimh topic 002 - development of novel in-vitro and in-vivo models to support neurohiv research) vala sciences INC.:1165050 [24-004928]
Ended Definitive Contract Awarded Last action
- Contract number
- 75N95024C00035
- Awardee
-
Vala Sciences Inc. UEI CZZJVX2BKJF3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $300,000
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals Pre-Solicitation · PHS20241 · Posted Jul 7, 2023
- Contract value 100% obligated
- $300,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $300,000 |
About this award
This is a $300,000.00 Firm Fixed Price Definitive Contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Vala Sciences Inc. to conduct Small Business Innovation Research (SBIR) Phase I research and development on the "Development of Novel In-Vitro and In-Vivo Models to Support NeuroHIV Research." The contract was set aside for small businesses and has an ultimate completion date of September 26, 2025. Vala Sciences Inc. is a for-profit company that has previously received federal contracts and grants to develop assays, screening platforms, and imaging systems for pharmaceutical testing and research, including work with human induced pluripotent stem cell-derived neural cells.
Quick answers
Who was awarded contract 75N95024C00035?
75N95024C00035 was awarded to Vala Sciences Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 27, 2024.
How much is contract 75N95024C00035 worth?
The government has obligated $300,000 on 75N95024C00035.
Was contract 75N95024C00035 competed?
The extent of competition for 75N95024C00035 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award